TCV Trust & Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

TCV Trust & Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-393	Closed	-$205K	–	194
2023 Q2	$205K	Hold	393	–	–	0.02%	184
2023 Q1	$227K	Buy	+393	New	+$222K	0.03%	177
2020 Q1	–	Sell	-780	Closed	-$253K	–	188
2019 Q4	$253K	Hold	780	–	–	0.03%	175
2019 Q3	$227K	Sell	780 -18	-2%	-$5.15K	0.03%	182
2019 Q2	$234K	Buy	798 +3	+0.4%	+$826	0.03%	183
2019 Q1	$217K	Buy	+795	New	+$198K	0.03%	199

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

TCV Trust & Wealth Management's TMO Position: Q3 2023 in Review

TCV Trust & Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 393 shares — an estimated $205K sold.

TCV Trust & Wealth Management first reported a position in TMO in Q1 2019 and held it in 6 quarters. The position peaked at $253K in Q4 2019. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

TCV Trust & Wealth Management reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
TCV Trust & Wealth Management sold 393 Thermo Fisher Scientific shares in Q3 2023, an estimated $205K.
TCV Trust & Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2019 and held it in 6 quarters.
TCV Trust & Wealth Management's Thermo Fisher Scientific position peaked at $253K in Q4 2019.
2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on TCV Trust & Wealth Management's 13F filing for Q3 2023, filed 19 Oct 2023.